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Abstract
Background: While HIV incidence has stabilized in many settings, increases in health and wellbeing among many
people living with HIV/AIDS suggest that the number of HIV-serodiscordant relationships is growing. Given the
deficit of reviews addressing social and behavioural characteristics of HIV-serodiscordant couples within high-income
settings, our objective was to understand the scope of the published literature, identify evidence gaps, and suggest
future research needs.
Methods: Ten electronic databases were searched. Studies were included if they were reported in English, used
primary data, were from the combination antiretroviral (cART) era (>1996), reported on social or behavioural
aspects, included any fraction of primary (i.e., stable) relationships, and were conducted in high-income settings.
Studies that identified their unit of analysis as either the dyad or individual member of the couple were included.
Studies were coded according to a thematic framework.
Results: Included studies (n = 154) clustered into eight themes: risk behaviours (29%), risk management (26%),
reproductive issues (12%), relationship quality (9%), serostatus disclosure (7%), adherence to antiretroviral therapy (7%),
vulnerability (5%), and social support (3%). The proportion of studies conducted among heterosexual couples, same-sex
male couples, and mixed cohorts were 42%, 34%, and 24%, respectively. Most studies (70%) were conducted in the
United States, 70% of all studies were quantitative (including interventions), but only one-third were focused on couples
(dyads) where both partners are recruited to a study. Over 25% of studies focused on sexual risk among same-sex male
couples.
Conclusions: Future research efforts should focus on the interrelationship of risk management strategies and
relationship quality, social determinants of health and wellbeing, HIV testing, vulnerable populations, reproductive issues
among same-sex couples, disclosure of serodiscordant status to social networks, dyadic studies, population-based studies,
and interventions to support risk management within couples. Additional population-based studies and studies among
marginalized groups would be helpful for targeting research and interventions to couples that are most in need.
As HIV-positive partners are typically the link to services and research, innovative ways are needed for reaching
out to HIV-negative partners. Our review suggests that significantly more research is needed to understand the
social and behavioural contexts of HIV-serodiscordant relationships.
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Background
Advances in HIV treatment and prevention have helped to
stabilize HIV incidence in many countries. Concomitant
increases in life expectancy and stabilized prevalence
suggest that the number of primary HIV-serodiscordant
couples (e.g., “serodiscordant couples” of mixed HIV sta-
tus in which one partner is HIV-positive and the other is
not, and who co-exist in a stable relationship) will in-
crease [1,2]. Estimates suggest that in Sub-Saharan Africa,
approximately half of HIV-positive persons in stable
relationships have an HIV-negative partner [3]; however,
there is an absence of similar data in high-income settings
[4-6]. Given that regular sexual contact introduces a rou-
tine risk of HIV transmission, HIV-serodiscordant couples
are a key population in which to understand how social
and behavioural factors may affect risk perception and
management, and inform comprehensive HIV prevention
measures.
Although combination antiretroviral therapy (cART) has
been shown to reduce the rate of new HIV infections
within serodiscordant couples by 96% [7,8], the social
and behavioural challenges that influence the successful
scaling-up and integration of cART within serodiscordant
relationships in non-trial, real-world settings are not
fully understood. Pre-cART studies explored social and
behavioural issues experienced by serodiscordant couples
[9-14]; however, with advances in treatment, these issues
are highly dynamic in the cART era. Behavioural interven-
tions such as Couples HIV Testing and Counselling
(CHTC) and HIV prevention educational interventions
are not well understood among this key population. Their
unique challenges include the management of sexual and
emotional risk within the context of rapidly evolving treat-
ment choices, illness-related stressors, HIV stigma within
social networks, and a lack of supportive services, espe-
cially for the HIV-negative partner. In terms of levels of
analysis, it is not clear whether most work in this area has
primarily focused on the discordant dyad or individ-
ual partners within the couple and there have been no
attempts to draw these different research approaches
together into a single review.
Overall, there are no reviews that have synthesized
knowledge in this area with the aim of identifying major
gaps in evidence. Therefore, our main objective was to
conduct a scoping review of the published literature in
order to identify key evidence gaps and suggest future
research needs in the field of HIV-serodiscordance.
Methods
Scoping reviews are used to map a field of study and to
determine the value in undertaking further systematic re-
views or studies by helping to identify important evidence
gaps [15]. For this review, PRISMA guidelines were
adopted and used to help standardize reporting [16]. Ten
electronic databases (Medline, EMBASE, CINAHL,
Cochrane Collaboration, JSTOR, PsychInfo, Scopus,
Web of Science, Sociological Abstracts, and Social
Work Abstracts) were searched from November to
December 2012. Search terms included “human immuno-
deficiency virus”, “HIV”, “acquired immune deficiency
syndrome”, “AIDS”, “relation”, “relationships”, “couple”,
“marriage”, “partner”, “spouse”, “serodiscordan*” and their
equivalent Medical Subject Heading (MeSH) terms. These
terms were combined using the generic formula: “HIV”
and “serodiscordant” and “relationship”. For a sample
search strategy, please see Additional file 1. No restric-
tions were initially applied with respect to geographic loca-
tion, date, or language. After removing duplicates and
mapping recurrent themes [17], we opted to focus the re-
view by excluding citations that were not reported in
English, did not report primary data, were conducted
in the pre-cART era (≤1996), reported exclusively on
casual or undefined relationships, did not report on social
or behavioural aspects, or were conducted in low and
middle-income settings [18]. We reviewed each study at
the full-text review stage for evidence of a distinction
between primary (i.e., stable) and casual relationships
and included any study that incorporated any fraction
of couples or individuals who were engaged in a pri-
mary relationship. Studies of social and behavioural as-
pects were included, while those covering clinical or
biomedical topics (e.g., sperm washing), were excluded.
Research on biomedical prophylaxes (e.g., treatment-
as-prevention, TasP, or pre-exposure prophylaxis, PrEP)
were included if the work focused on social or behavioural
aspects. We opted to distinguish low- and middle-income
settings from high-income settings and to focus the
present review on the latter, given that disparate resource
levels contribute to distinct socio-structural environments
worthy of separate consideration. Studies that identified
their unit of analysis as either the dyad (i.e., both members
of the couple), as the individual member of the couple,
or both, were included in this review.
One of two reviewers (SM or JP) made exclusion deci-
sions. Citations for which exclusion criteria were incon-
clusive were noted and discussed. Where agreement
could not be reached, the opinion of a third reviewer
(JM) was solicited. The references cited list of all in-
cluded articles identified within the original search of
health science databases were checked for additional rele-
vant citations. Following a framework analytic approach
[19], we undertook a preliminary reading of included stud-
ies and developed an initial thematic framework based on
the main outcomes reported. One researcher assigned
each study to a primary theme within this framework. As
coding progressed, new themes were incorporated into
the framework and previously coded studies were re-
assessed within the updated framework. Once a final
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framework was obtained, primary themes were assigned
to each study by one researcher, and were validated by a
second researcher. Discrepancies were discussed and re-
solved. Where appropriate, studies were assigned primary
and secondary themes. For ease of presentation, results of
included studies were grouped according to the primary
theme. Each study was also categorized according to study
location, methodology, population risk group, serostatus
of included participants, and unit of analysis (i.e., individ-
ual or dyad) (see Table 1). This scoping review did not
involve primary research with human subjects and there-
fore did not warrant institutional ethical approval.
Results
Searches yielded a total of 2,133 citations, of which 154
were included in this review (Figure 1). These citations
clustered according to eight primary themes: sexual risk
behaviours (29%; 45/154), risk management (26%; 40/154),
reproductive issues (12%; 19/154), relationship quality (9%;
14/154), serostatus disclosure (7%; 12/154), adherence to
cART (7%; 11/154), vulnerability (5%; 8/154), and social
support (3%; 5/154). The proportions of included studies
that were conducted among heterosexual serodiscordant
couples, same-sex male couples, and mixed cohorts were
42% (64/154), 34% (53/154), and 24% (37/154), re-
spectively. Over 70% (109/154) were conducted within
the United States, 21% (32/154) were European, and
8% (13/154) were Australian. The focus of over one-quarter
of identified studies was sexual risk behaviours among
same-sex male couples (Figure 2). Methodologically, 70%
(108/154) of studies used quantitative methods (6%; 9/154
were intervention studies), 25% (39/154) used qualitative
methods, and 5% (7/154) were mixed methods. Half of
qualitative studies (21/39) were conducted among indi-
viduals or couples within heterosexual serodiscordant
relationships. One-third (53/154) of studies used a
dyadic unit of analysis, meaning that both partners
participated in the study. Intervention studies (counted
as quantitative studies) included behavioural interven-
tions to reduce sexual risk behaviours [20-24], a small
psycho-education group intervention to reduce depres-
sion and anxiety and increase marital satisfaction [25], an
intervention to improve adherence to cART [26], and two
interventions for improving social support [27,28].
Sexual risk behaviours
The “sexual risk behaviour” theme was assigned to any
study that assessed the prevalence of, or risk factors as-
sociated with, sexual risk behaviours. Relationships of
longer duration were typically associated with more
sexual risk, while evidence of the association between
risky sexual behaviours and relationship type was
mixed. Among a cohort of heterosexual partners re-
cruited in California, longer relationship duration was
associated with unprotected vaginal intercourse (UVI)
but not relationship type (e.g., primary or casual) [29].
In a French study conducted among HIV-positive het-
erosexual individuals engaged in regular serodiscor-
dant relationships or relationships of unknown status,
sexual risk was linked to relationships of >10 years
duration, financial difficulties, and routine excessive
alcohol consumption among men [30]. Among HIV-
positive heterosexual American men, UVI was associated
with being in a primary partnership, age, sex with men,
and exchanging sex for money or drugs [31]. In a com-
parison of American men and women with casual and
regular serodiscordant partners, there was a fourfold in-
crease in the risk that regular partners had UVI [32].
Among African-American HIV-negative men who have
sex with men (MSM), being in a non-primary partnership
was the only factor associated with serodiscordant or ser-
ostatus unknown unprotected anal intercourse (UAI) [33].
However, among Latino MSM, serodiscordance, serosta-
tus disclosure, and relationship type (e.g., primary, casual)
were not associated with sexual risk [34]. HIV-positive
methamphetamine-using MSM engaged in risky sex with
a range of partner types including steady, casual and an-
onymous partners, but less UAI was reported among
those in serodiscordant relationships [35].
In some studies, couples appeared to manage and re-
duce risky sex when compared with other groups. For
example, American MSM in primary seroconcordant re-
lationships reported significantly more UAI and were
more likely to have sex outside of their relationships
when compared with those in primary serodiscordant re-
lationships; yet, the impact of the level of intimacy on
risky sex was moderated by drug use before sex and the
partners’ HIV status [36-38]. In studies of mental health,
depressed HIV-positive partners were less likely to re-
port unprotected sex but more likely to have outside
partners [39,40]. Among American HIV-negative part-
ners in serodiscordant relationships, “sensation-seeking”
increased risky sex by 3–5 times [41].
Among women, those who were HIV-positive and in
primary partnerships were more likely to have unpro-
tected sex than HIV-positive women without partners in
the US [42]. Women who binged on alcohol or were on
cART were also more prone to risky sexual behaviour
[43]. Among female IDUs, inconsistent condom use was
more likely to occur in relationships where mutual dis-
closure of HIV status had not occurred [44]. Among
transgender women, risk behaviours were not associated
with type or duration of relationship; however, living
with a primary partner, drug and alcohol use, education
level, low condom self-efficacy, and perceived discrimin-
ation were associated with unprotected sex among pri-
mary serodiscordant couples [45]. Among men with a
primary discordant transgender partner, risk factors for
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Table 1 Summary of included studies
1st author Year Ref # Country Type N (n, SD) Theme Population Unit of analysis Serostatus
✓ RM RB RQ RI SD AD SS VU MM HE WW BI IN DY + -
Aidala 2006 [31] US CO 278 ✓(2) ✓(1) ✓ ✓ ✓ ✓
Aoki 2004 [115] US QL 1 ✓(1) ✓ ✓ ✓
Asandar 2009 [112] SWD QL 47 ✓(1) ✓(2) ✓ ✓ ✓
Bairan 2007 [86] US QL 104 ✓(1) ✓ ✓ ✓ ✓
Beckerman 2000 [116] US CS 82 ✓(1) ✓(2) ✓ ✓ ✓ ✓ ✓
Beckerman 2002 [117] US QL 24 ✓(1) ✓(2) ✓(3) ✓ ✓ ✓ ✓ ✓
Beckerman 2002 [118] US MX 82 ✓(1) ✓ (2) ✓ ✓ ✓ ✓ ✓
Beckerman 2002 [119] US QL 82 ✓(1) ✓(3) ✓ (2) ✓ ✓ ✓ ✓ ✓
Blashill 2012 [39] US CS 430 ✓(1) ✓ ✓ ✓
Bouhnik 2007 [30] FR CS 663 ✓(1) ✓ ✓ ✓
Bradley 2008 [40] US CS 394 ✓(1) ✓ ✓ ✓ ✓ ✓
Brooks 2011 [120] US QL 50 ✓(1) ✓(2) ✓ ✓ ✓ ✓ ✓
Brooks 2012 [121] US QL 25 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Buchacz 2001 [122] US CS 290 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Chakravarty 2012 [59] US CS 752 ✓(1) ✓ ✓ ✓
Chen 2001 [123] US CS 1421 ✓(1) ✓ ✓ ✓ ✓ ✓
Chin 1999 [87] US MX 9 ✓(1) ✓(2) ✓ ✓ ✓
Coll 1999 [124] SP CS 280 ✓(2) ✓(1) ✓ ✓ ✓ ✓
Cooney 2009 [125] UK CS 69 ✓(1) ✓i ✓ ✓
Corbett 2009 [126] US QL 100 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Crane 2002 [98] US QL 65 ✓ (1) ✓ ✓ ✓ ✓
Cranson 1998 [127] US QL 29 ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓ ✓
Crawford 2001 [62] AU CS 1070 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Crawford 2003 [37] US CS 230 ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓
Crawford 2006 [128] AU CS 903 ✓(2) ✓(1) ✓ ✓ ✓ ✓
Crosby 2007 [129] US CS 1006 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Cusick 1999 [84] UK QL 73 ✓(1) ✓ ✓ ✓ ✓ ✓ ✓
Cusick 2000 [64] UK QL 73 ✓(1) ✓(2) ✓ ✓ ✓ ✓ ✓ ✓
Dave 2006 [69] UK CS 142 ✓(1) ✓(2) ✓ ✓ ✓
Davidovich 2001 [130] ND CO 144 ✓(1) ✓ ✓ ✓
Davis 2011 [65] UK QL 16 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Dolezal 2005 [131] US CS 234 ✓(2) ✓(1) ✓ ✓ ✓ ✓
M
endelsohn
et
al.BM
C
Public
H
ealth
 (2015) 15:241 
Page
4
of
18
Table 1 Summary of included studies (Continued)
Doyal 2005 [97] UK QL 62 ✓(1) ✓ ✓ ✓
Eaton 2008 [52] US CS 290 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Eaton 2009 [132] US CS 254 ✓(1) ✓ ✓ ✓ ✓
Eaton 2009 [133] US CS 290 ✓(1) ✓ ✓ ✓ ✓
El-Bassel 2010 [99] US CS 1070 (535) ✓(2) ✓(1) ✓ ✓ ✓ ✓
El-Bassel 2010 [21] US RCT 1070 (535) ✓(1) ✓(2) ✓ ✓ ✓ ✓
El-Bassel 2010 [60] US CS 1070 (535) ✓(1) ✓ ✓ ✓ ✓
El-Bassel 2010 [134] US CS 1070 (535) ✓(1) ✓ ✓ ✓ ✓
El-Bassel 2010 [135] US CS 1070 (535) ✓(1) ✓ ✓ ✓ ✓
Elford 1999 [56] UK CS 1004 ✓(1) ✓ ✓ NR NR
Elford 2008 [111] UK CS 1687 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Estes 1997 [136] US CS 60 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Fife 2008 [28] US RCT 169 ✓(2) ✓(3) ✓(1) ✓ ✓ ✓ ✓ ✓ ✓ ✓
Fletcher 2012 [72] US QL 42 ✓(1) ✓ ✓ ✓
Fox 2009 [61] UK CO 78 ✓(2) ✓(1) NR NR NR NR ✓ ✓ ✓
Galvan 2004 [137] US CS 1421 ✓(1) ✓ ✓ ✓ ✓
Gaskins 2009 [79] US CR 2 ✓ (1) ✓ ✓ ✓
Gielen 2000 [138] US MX 310 ✓(2) ✓(1) ✓ ✓ ✓
Gordon-Garofa 2004 [27] US QUA 29 ✓(2) ✓(1) ✓ ✓ ✓ ✓
Gosselin 2011 [71] US CS 286 ✓(1) ✓ ✓ ✓ ✓
Greenberg 2001 [88] US CS 238 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Guy 2011 [139] AU CO 7857 ✓(1) ✓ ✓ ✓ ✓
Guzman 2006 [48] US CS 199 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Haas 2002 [101] US QL 40 ✓(2) ✓(1) ✓ ✓ ✓ ✓
Hart 2005 [70] US CS 456 ✓(1) ✓(2) ✓ ✓ ✓
Heard 2004 [140] FR CO 575 ✓(1) ✓ii ✓ ✓
Heard 2007 [141] FR CO 1254 ✓(1) ✓ ✓ ✓
Hernando 2009 [24] SP CO 1128 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Hoff 2004 [36] US MX 245 ✓(1) ✓ ✓ ✓
Hoff 2009 [57] US CS 382 (90) ✓(1) ✓ ✓ ✓ ✓
Hoff 2010 [63] US QL 78 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Horvath 2012 [47] US CS 326 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Hotton 2011 [142] US CS 793 ✓(1) ✓(2) ✓ ✓ ✓ ✓
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Table 1 Summary of included studies (Continued)
Hunt 1999 [143] US CS 52 ✓(1) ✓(1) ✓ ✓ ✓ ✓
Israel 2005 [41] US CS 74 ✓(1) ✓ ✓ ✓ ✓ ✓
Jarman 2005 [144] UK QL 6 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Johnson 2011 [90] US CS 420 ✓(1) ✓ ✓ ✓ ✓ ✓
Kalichman 1999 [80] US CS 266 ✓(2) ✓(1) ✓iii ✓ ✓ ✓
Kalichman 1999 [145] US CS 331 ✓(1) ✓(2) ✓iv ✓ ✓ ✓ ✓ ✓
Kalichman 2002 [32] US CS 383 ✓(1) ✓ ✓ ✓ ✓ ✓
Kelly 2011 [74] UK QL 10 ✓(3) ✓(2) ✓(1) ✓ ✓ ✓
Klein 2003 [146] US MX 100 ✓(1) ✓v ✓ ✓ ✓
Knight 2005 [147] US MX 161 ✓(1) ✓(2) ✓ ✓ ✓ ✓ ✓
Knowlton 2011 [92] US CS 145 ✓(1) ✓(2) ✓vi ✓ ✓
Knowlton 2011 [94] US CS 104 ✓(1) ✓(2) ✓vii ✓ ✓
Latka 2006 [44] US CS 426 (292) ✓(1) ✓(2) ✓ ✓ ✓
Liu 2011 [68] US CO 2266 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Lopez 2010 [148] US CO 190 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Marks 2001 [149] US CS 206 ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓
Marujo 2012 [150] PO CO 71 ✓(1) ✓ ✓ ✓
McDonald 2011 [151] AU QL 34 ✓(2) ✓(1) ✓ ✓ ✓
McFarland 2011 [152] US CS 1207 ✓(1) ✓(2) ✓ ✓ ✓ ✓
McFarland 2012 [153] US CO 732 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Milam 2006 [29] US CS 121 ✓(1) ✓ ✓ ✓
Mizuno 2007 [154] US CS 348 ✓(2) ✓(1) ✓(2) ✓ ✓ ✓
Myers 2006 [100] US CS 147 ✓(2) ✓(1) NR ✓ ✓
Nakhuda 2005 [155] US CR 5 ✓(1) ✓ ✓ ✓
Niccolai 2002 [81] US CS 76 ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓ ✓
Nichols 2006 [156] US CS 150 ✓(1) ✓(2) ✓ ✓ ✓ ✓
NIMH 2008 [20] US MX 86 ✓(2) ✓(1) ✓ ✓ ✓ ✓
Noestlinger 2012 [73] EU CS 427 ✓(1) ✓ ✓ ✓
Nostlinger 2010 [157] EU CS 651 ✓(1) ✓(2) ✓ ✓ ✓
Operario 2011 [46] US CS 174 ✓(1) ✓ ✓ ✓ ✓ ✓
Operario 2011 [45] US CS 174 ✓(1) ✓ ✓ ✓ ✓ ✓
Ostrow 2002 [105] US CS 547 ✓(2) ✓(1) ✓ ✓ ✓ ✓
Ostrow 2008 [58] US CO 501 ✓(2) ✓(1) ✓ ✓ ✓ ✓
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Table 1 Summary of included studies (Continued)
Palmer 2001 [78] UK QL 20 ✓(2) ✓(1) ✓(3) ✓ ✓ ✓ ✓
Panozzo 2003 [158] SW CS 114 ✓(3) ✓(2) ✓(1) ✓ ✓ ✓
Parish 2001 [159] US QL 79 ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓
Parsons 2004 [82] US MX 158 ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓
Parsons 2005 [160] US CS 1168 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Peretti-Watel 2006 [96] FR CS 1809 ✓(2) ✓(1) ✓(3) ✓ ✓ ✓ ✓ ✓
Persson 2011 [77] AU QL 14 ✓(2) ✓(1) ✓ ✓ ✓
Persson 2008 [76] AU QL 46 ✓(1) ✓ ✓ ✓ ✓ ✓
Persson 2008 [161] AU QL 16 ✓(3) ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓
Persson 2010 [54] AU QL 27 ✓(2) ✓(1) ✓(3) ✓ ✓ ✓ ✓ ✓
Poindexter 2003 [162] US QL 2 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Pomeroy 2002 [25] US QUA 24 ✓(1) ✓ ✓ ✓ ✓
Poppen 2005 [34] US CS 219 ✓(3) ✓(1) ✓(2) ✓ ✓ ✓
Prestage 2008 [163] AU CS 23424 (2489) ✓(1) ✓ ✓ ✓ ✓
Prestage 2009 [49] AU CO 1006 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Reilly 2001 [164] US CS 360 ✓(1) ✓ ✓ ✓ ✓ ✓ ✓
Reilly 2004 [165] US CS 360 ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓ ✓
Remien 2005 [26] US RCT 430 ✓(1) ✓ ✓ ✓ ✓ ✓ ✓ ✓
Rhodes 2000 [66] UK QL 73 ✓(1) ✓(2) ✓ ✓ ✓ ✓ ✓ ✓ ✓
Ritchie 2012 [166] UK CO 275 (192) ✓(1) ✓ ✓ ✓ ✓ ✓
Ross 2008 [167] US CS 675 ✓(1) ✓(3) ✓(2) ✓ ✓ ✓
Rosser 2010 [22] US RCT 675 ✓(1) ✓(2) ✓ ✓ ✓
Schonnesson 2008 [168] US CS 258 ✓(1) ✓ ✓ ✓
Semple 2002 [169] US CS 47 ✓(1) ✓ ✓ ✓
Semple 2006 [35] US CS 132 ✓(1) ✓(2) ✓ ✓ ✓
Service 2006 [170] US CS 604 (172) ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓
Sherr 2004 [171] UK CS 32 ✓(1) ✓ ✓ ✓
Simoni 2000 [42] US CS 105 ✓(1) ✓(2) ✓ ✓ ✓
Sowell 1999 [172] US CS 45 ✓(1) ✓ ✓ ✓
Sowell 2003 [85] US MX 322 ✓(1) ✓ ✓ ✓
Stevens 2007 [173] US QL 55 ✓(1) ✓(2) ✓ ✓ ✓
Stirratt 2006 [95] US CS 215 ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓ ✓
Stolte 2004 [53] ND CO 57 ✓(1) ✓(2) ✓ ✓ ✓
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Table 1 Summary of included studies (Continued)
Stumbo 2011 [174] US QL 40 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Sullivan 2009 [83] US CS 99 ✓(2) ✓(1) ✓ ✓ ✓ ✓ ✓
Sunderam 2008 [75] IT QL 33 ✓(1) ✓ ✓ ✓ ✓ ✓
Suzan-Monti 2011 [175] FR CS 322 ✓(1) ✓ ✓ ✓
Theall 2007 [43] US CS 187 ✓(1) ✓(2) ✓viii ✓ ✓
Theodore 2004 [38] US CS 87 ✓(1) ✓(2) ✓ ✓ ✓
Tieu 2011 [33] US CS 328 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Turner 1998 [176] US CS 642 ✓(1) ✓ix ✓ ✓ ✓ ✓
Van de Ven 2002 [177] AU CS 14156 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Van de Ven 2005 [50] AU CS 119 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Van der Straten 2000 [51] US CS 208 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Van Leeuwen 2008 [178] ND CS 100 ✓(1) ✓ ✓ ✓ ✓
Vide Tavares 2012 [179] PO CS 133 ✓(1) ✓x ✓ ✓
Wagner 2002 [89] US CS 80 ✓(1) ✓ ✓ ✓ ✓ ✓
Weinhardt 2004 [180] US CS 3723 ✓(1) ✓ ✓ ✓ ✓ ✓ ✓ ✓
Wilson 2007 [104] US CO 1090 ✓(1) ✓(2) ✓ ✓ ✓
Wolitski 2003 [181] US CS 250 ✓(1) ✓(2) ✓ ✓ ✓
Wrubel 2008 [93] US QL 40 ✓(1) ✓ ✓ ✓ ✓
Wrubel 2010 [91] US QL 40 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Wyatt 2004 [23] US RCT 147 ✓(1) ✓(2) ✓(3) ✓(4) ✓xi ✓ ✓
Wyatt 2012 [182] US CR 2 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Xia 2006 [67] US CS 354 ✓(1) ✓(2) ✓ ✓ ✓ ✓
Zablotska 2011 [183] AU CO 16022 ✓(1) ✓(2) ✓ ✓ ✓ ✓
i Population not explicitly stated; assumed heterosexual because sample of women address fertility needs.
ii Population not explicitly stated; assumed heterosexual because a majority of women contracted HIV through heterosexual contact.
iii Population not explicitly stated; assumed men who have sex with men, and heterosexual because of sexual acts reported.
iv Population not explicitly stated; assumed men who have sex with men, heterosexual, women who have sex with women and bisexual because of partners reported.
v Population not explicitly stated; assumed heterosexual because sample included men and women in couples with whom fertility concerns were explored.
vi Population not explicitly stated; assumed heterosexual because a majority of men contracted HIV through heterosexual contact.
vii Population not explicitly stated; assumed heterosexual because a majority of women contracted HIV through heterosexual contact.
viii Population not explicitly stated; assumed heterosexual because a majority of women contracted HIV through heterosexual contact.
ix Population not explicitly stated; assumed men who have sex with men, heterosexual and bisexual because of sample characteristics.
x Population not explicitly stated; assumed heterosexual because the sample of women addressed contraception use.
xi Population not explicitly stated; assumed heterosexual because of sexual acts reported.
Legend. LOCATION: United States (US); United Kingdom (UK); Australia (AU); Multiple European Union Countries (EU); France (FR); Italy (IT); Netherlands (ND); Spain (SP); Sweden (SWD); Switzerland (SW); Portugal (PO).
TYPE: cross-sectional study (CS); case control (CC); case report (CR); cohort study (CO); quasi-experimental (QUA) randomized controlled trial (RCT); qualitative study (QL); mixed methods (MX). THEME: risk management
(RM); sexual risk behaviours (RB); relationship quality (RQ); reproductive issues (RI); serostatus disclosure (SD); adherence (AD); social support (SS); vulnerability (VU). POPULATION: men who have sex with men (MM);
heterosexual (HE); women who have sex with women (WW); bisexual (BI). UNIT OF ANALYSIS: individual (IN); dyad (DY). SEROSTATUS: HIV-positive (+); HIV-negative (−). SAMPLE SIZE: no. serodiscordant (n,SD). Data not
reported (NR).
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unprotected sex were younger age, concurrent part-
nerships, alcohol intoxication, and low condom use
self-efficacy [46].
Risk management
The “risk management” theme was assigned to studies
that focused on efforts to avoid or manage the risk of in-
fection and included work on condom use, PrEP, viral
load knowledge, negotiated safety agreements, seroadap-
tation (e.g., “seropositioning” or selection of partners ac-
cording to serostatus and “serosorting” or strategic
positioning during sexual intercourse), HIV testing, and
serostatus disclosure.
Given that it is now accepted that an undetectable
viral load reduces the risk of infection, investigations
into the effects of actual and perceived viral load are of
particular interest. An online survey that studied the im-
pact of viral load discussions on risky sex among American
MSM found that UAI occurred within 25% of primary ser-
odiscordant couples who had discussed their viral load
together [47]. A study in San Francisco found that viral
load discussions were not more common among men
in serodiscodant primary relationships compared with
men who were not in such relationships; however,
HIV-negative men who typically discussed viral load
reported that they would be more inclined to take sex-
ual risks with their HIV-positive partners whose viral
load was undetectable [48]. In Australian studies, hav-
ing an undetectable viral load was associated with a
threefold increase in the odds of UAI among same-sex
male serodiscordant couples and was more likely to be
reported by seronegative partners when they believed
;
Figure 1 Study selection flowchart.
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their HIV-positive partner’s viral load was undetectable
[49,50]. In the California Partners II study, HIV-negative
partners estimated a lower likelihood of HIV transmission
and had riskier sex if they thought that their partner was
on cART and had an undetectable viral load [51,52].
Favourable perceptions of viral load among HIV-positive
MSM based in Amsterdam led to increases in risk behav-
iours with seronegative or unknown status partners when
compared with men who had an unfavorable perception
of their viral load, even after adjusting for actual viral load
and CD4 counts [53]. In an Australian qualitative study,
perceptions of viral load, infectiousness, and safety of un-
protected sex were linked to emotional sensibilities and
commitments, as much as risk calculations [54].
Negotiated safety agreements (i.e., the negotiation of mu-
tually agreed strategies for managing HIV risk within sexual
relationships) and seroadaptation were the most commonly
discussed behavioural risk management strategies within
the surveyed literature [55]. Between 26% and 91% of
cohorts included in this review reported having used
sexual agreements [56-59]. Among African-American
serodiscordant couples, “couple agreement” in reporting
of sexual risk behaviours was consistent [60]; however, in-
dividual partners were found to hold different perceptions
of transmission risk [61]. Among same-sex male couples
based in Australia, sexual agreements that included casual
serodiscordant partners, or having no agreement, were as-
sociated with UAI [62]. Qualitative work conducted in San
Francisco found very little uniformity in the rules of nego-
tiated agreements across couples [63]. In a British study,
HIV-negative partners in both heterosexual and same-sex
primary serodiscordant couples often requested risky sex
in order to demonstrate love and relationship investment,
or to reinforce trust within the relationship. This finding
reinforces the importance of understanding the emotional
and intimate dynamics of relationships when designing
interventions [64,65]. In critiquing the focus on the in-
dividual costs and benefits of risk management, a British
qualitative study noted that research on sexual risk decision-
making often ignored the intimate and emotional experience
of couples, the major context in which such decision-
making is undertaken [66]. Seroadaptive behaviours include
seropositioning (i.e., where seronegative men position them-
selves as the insertive partner) and serosorting (i.e., selection
of partners on the basis of serostatus). Seropositioning was
adopted by 58% of HIV-negative MSM in a population-
based study in California [67]. Among women based in six
US cities, both HIV-positive and seronegative female part-
ners engaged in serosorting [68].
In studies that explored associations between risk
management and HIV serostatus disclosure, knowledge
of a heterosexual partner's HIV status was associated
with condom use among those who had disclosed their
serostatus [69]. Frequencies of risk behaviour were
similar among MSM whether they were consistently
aware or unaware of their partners’ HIV infection [70].
In the only study that examined HIV testing, 72% of
seronegative men in same-sex serodiscordant couples
who reported UAI with their HIV-positive primary
partner or had UAI with an outside partner of discord-
ant or unknown status had tested for HIV in the past
year [59].
Four studies reported on interventions that aimed to re-
duce sexual risk behaviours. In a cluster randomized trial
of a risk reduction intervention for African-American ser-
odiscordant couples that addressed stigma and psycho-
logical distress, barriers to condom use, support from
community organizations, and relationship skills, a lower
Figure 2 Citations stratified by risk group and thematic area (1 = risk behaviours; 2 = risk management; 3 = reproductive issues; 4 = relationship
quality; 5 = serostatus disclosure; 6 = adherence; 7 = vulnerability; 8 = social support).
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adjusted mean number of unprotected sex acts was found
in the intervention group [21]. In a non-randomized
Spanish trial that evaluated the impact of a Couples’
Counselling and Testing intervention on sexual risk, pre-
intervention sexual risk behaviour, >35 years of age, and a
recent pregnancy increased the odds of post-intervention
risky sexual behaviour by 2–3 times [24]. A randomized
controlled trial of two sexual health seminars conducted
among MSM found that UAI frequency decreased in all
study conditions despite better reported intentions to
avoid transmission among those in the intervention arms
[22]. In a US-based psycho-educational intervention
designed to decrease sexual risk and improve adherence
to cART among heterosexual HIV-positive women with
histories of child sexual abuse, the intervention was asso-
ciated with a threefold increase in the odds of reducing
sexual risk while those who attended ≥8 sessions reported
a fourfold improvement in adherence compared to the
control group [23]. Although there is some evidence that
interventions have a positive impact on sexual risk behav-
iours among serodiscordant couples, overall there is a
paucity of evidence from which to draw.
Reproductive issues
Studies were assigned the “reproductive issues” theme if
they focused primarily on any social or behavioural aspect
of reproduction or fertility. Notably, studies classified
within this theme were conducted exclusively among
heterosexual serodiscordant couples. In one study of
American couples’ desire to conceive through assisted
reproduction where the majority of men in the study
had previously been diagnosed with HIV, participants
were most concerned about the risk of transmission
within the family, premature death of the HIV-positive
partner, disclosure of HIV status to children, and the poten-
tial desire for additional children if assisted reproduction
proved successful on the first attempt [71]. In a qualitative
study, 93% of participating women in South Carolina had
no desire to become pregnant due to concerns about HIV
transmission to the fetus, financial instability, single re-
lationship status, age, and previous childbearing or
child rearing experiences [72]. A European study that
explored satisfaction with sexual and reproductive health
services reported that 58% of all participants (59% of sam-
ple were in a serodiscordant couple) were not satisfied
with services delivered in HIV care settings, while a third
of participants reported HIV-related discrimination in
healthcare settings [73]. Qualitative work conducted in
Northern Ireland found that love, commitment, physical
pleasure, and a desire to conceive without medical interven-
tions helped to shape perceptions of risk within the relation-
ship [74]. Among Italian couples consisting of HIV-positive
men and seronegative women, assisted reproduction was
typically regarded as safe and effective [75].
Relationship quality
Studies were assigned the “relationship quality” theme if
they explored relationship satisfaction or outcomes of
serodiscordant relationships. Two-thirds (11/18) of these
studies used qualitative methods. The “Straightpoz”
study, an Australian longitudinal cohort of serodiscor-
dant couples, found that HIV-positive partners felt that
their identities were “redeemed” by their seronegative
partners and revealed tensions within the couple sur-
rounding communication about serodiscordance [76,77].
Among gay male serodiscordant couples, relationship
balance and redefinition of the sexual relationship resulted
when serodiscordance was uncovered by the couple after
the relationship had started [78]. A pilot study testing a
psycho-educational group intervention for heterosexual
serodiscordant couples found reductions in depression
and anxiety and increases in marital satisfaction among
the intervention group [25].
Serostatus disclosure
Studies were assigned to the “serostatus disclosure”
theme if the primary finding was related to disclosure of
serostatus to partners, family, or wider social networks.
Serostatus disclosure, however, typically referred to indi-
vidual disclosure of HIV status to partners. The finding
that 41% and 47% of HIV-positive men and women en-
gaged in a serodiscordant couple, respectively, had not
disclosed their status to their partner [79,80] was con-
sistent with disclosure rates found in other studies
[81-83]. Qualitative work conducted in the UK suggested
that negative ideas about condoms, concerns about rela-
tionship quality, and limited communication within the
relationship, were barriers to disclosing serostatus to
partners [84]. In a mixed-methods study conducted
among American women, qualitative interviews revealed
that disclosure decisions for women were often based on
emotional closeness to their partner, or were organized
around a highly personalized (i.e., non-generalizable) set
of criteria [85]. In a study conducted among American
HIV-positive IDUs, there was a higher likelihood of dis-
closure to casual partners before first sexual contact
when compared to primary partners [82]. Disclosure of
HIV status to social networks appeared to present a dif-
ferent type of issue upon which very few studies have fo-
cused. A qualitative study conducted among MSM,
high-risk heterosexuals, and substance users found that
the type of social relationship (e.g., sexual vs non-sexual;
close vs not close) was a key consideration within the
disclosure decision process [86]. Among Asian/Pacific
Islanders, fears of stigma or discrimination, and con-
cerns about disappointing or burdening others, were im-
portant to the process of disclosing HIV status to social
networks [87]. HIV-positive partners were more likely
to disclose their serodiscordant relationship to social
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networks when compared with their seronegative
partners as a result of better self-reported social inte-
gration [88].
Adherence to antiretroviral therapy
Studies were classified within the “adherence” theme if
their main finding was related to cART adherence. Stud-
ies found that strong social support was linked to better
adherence by the HIV-positive partner within serodis-
cordant couples. In a pilot-study of 40 couples based in
the United States, higher adherence levels were associated
with less risk attribution to unprotected sex by seronega-
tive partners, better perceived treatment efficacy, good
knowledge of treatment, and the perceived negative con-
sequences of poor adherence [89]. Highlighting the im-
portance of dyadic approaches to the study of adherence
within couples, the seronegative partner’s estimate of ad-
herence was found to be a better predictor of viral sup-
pression than the HIV-positive partner’s own self-reported
adherence in a cohort of same-sex male couples [90,91].
Among men, adherence was strongly associated with
comfort in taking cART in the presence of close friends
and support from caregivers [92,93]. Among American
women, good adherence was 75% less likely among sero-
concordant couples when compared to serodiscordant
couples, and 78% less likely in situations where the HIV-
positive partner was dependent on emotional support
from their partner [94]. In a New York study that exam-
ined the relationship between HIV serostatus disclosure
and adherence, disclosure was independently associated
with better adherence [95]. In a French study that exam-
ined the co-occurrence of non-adherence to cART and
risky sex within serodiscordant couples, no differences
were observed in the proportions engaged in unsafe sex
by adherence level (high vs. non-) among MSM and het-
erosexual men; however, a positive association was found
among heterosexual women [96]. An educational and
counseling intervention to improve adherence among het-
erosexual and same-sex serodiscordant couples in New
York found short-term improvements in the proportion of
prescribed doses taken correctly by the HIV-positive part-
ner within the intervention group [26].
Vulnerability and social support
The “vulnerability” theme was assigned when the primary
contribution was a focus on understudied or highly mar-
ginalized groups such as migrants, those living in poverty,
or those who had suffered from abuse. Although IDUs are
highly vulnerable, these studies were typically assigned
to other themes, and secondarily coded within the vul-
nerability theme. Among immigrant women from sub-
Saharan Africa who were receiving HIV treatment in
the United Kingdom, vulnerability was described by
women as an interplay between migration, HIV status,
and poverty [97]. A qualitative study of 33 low-income,
marginally-housed, or substance using heterosexual
serodiscordant couples situated in California found
that HIV diagnosis was typically used as a commodity
that allowed individuals to retain their access to crucial
government programs that had been scaled back as a con-
sequence of welfare reforms [98]. In a study of adult and
child sexual abuse among African American serodiscor-
dant couples, 72% of couples reported a history of abuse
among one or both partners [99]. Child sexual abuse and
adult re-victimization were independent risk factors for
post-traumatic stress disorder and sexual trauma symp-
toms, but were not associated with risky sexual behaviour
among HIV-positive women [100].
In qualitative studies of social support, partners were
the primary source of support among same-sex male ser-
odiscordant couples, while less support was received
from families [101]. In a small quasi-experimental study
that evaluated the effect of a psychoeducational group
intervention on within-couple support, the intervention
did not increase perceived social support [27]. Moreover,
an intervention that attempted to improve coping and
social support within couples led to positive changes in
active coping, positive refocusing and less emotional dis-
tress, but did not result in a reported improvement in
social support [28]. Therefore, evidence-based, couple-
focused interventions that aim to increase supportive
relationships among serodiscordant couples are cur-
rently lacking.
Discussion
Through the process of reviewing the 154 included cita-
tions and assigning them to eight thematic categories,
this scoping review identified key gaps in the social
and behavioural evidence-base for HIV-serodiscordant
couples. Designing studies that will contribute to evi-
dence in these areas should inform future research.
The social and behavioural aspects of biomedical prophy-
laxis (e.g., adherence to TasP or PrEP), and impacts on
relationship quality and satisfaction were generally
underexplored. Moreover, although intimate couple
dynamics and emotional needs were important for
understanding patterns of risk in qualitative studies,
these factors were seldom addressed in quantitative
work [38,54,64,66]. Negative impacts on relationship
quality may affect the uptake of a range of risk manage-
ment strategies including negotiated safety agreements,
TasP, or PrEP [90,92-94,102,103]. In terms of prophylactic
ART, studies that investigate associations between these
strategies and relationship quality will be needed to better
understand the impact on primary relationships over the
long-term, especially at present when guidelines are shift-
ing towards recommending these strategies. Relatedly, in
studies that explored the effects of viral load perceptions
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on risk behaviours, actual or perceived viral load typically
affected risk management choices [48-51,53]. For example,
women who perceived ART to be protective reported in-
creased sexual risk taking [104,105]. A systematic review
addressing risk perceptions related to viral load and ART
effectiveness would be useful.
There is a considerable amount of work that has inves-
tigated sexual risk behaviours or management of sexual
risk, without taking account of the socio-structural fac-
tors that affect these outcomes. The social determinants
of health are “core social processes and arrangements –
reflective of social and cultural norms, values, networks,
structures and institutions – that operate in concert with
individual behaviours and practices to influence HIV
epidemics in particular settings” [106], p. S294-5. For
example, very few studies have explored the impact of
criminalization of non-disclosure of HIV status on re-
lationship quality [107]. The application of conceptual
frameworks that take into account the effects of social
and structural environments would facilitate a better
understanding of the interplay of individual, dyadic, and
social experience on relationship satisfaction within sero-
discordant couples.
The only quantitative study focused on HIV-testing
among HIV-negative partners was conducted in the
Unites States prior to a change in national guidelines
that recommended that higher risk individuals receive
an annual HIV test. This study found that nearly three-
quarters of HIV-negative partners in same-sex serodiscor-
dant relationships had tested for HIV in the previous year
[59,108,109]. Barriers or facilitators of HIV testing, espe-
cially for CHTC, were not specifically examined in any study
focused on serodiscordant couples. CHTC is normally
considered when the status of both partners is negative
and/or unknown; however, studies that investigate the
risks and benefits of involving the HIV-positive partner
in the seronegative partner’s testing might inform the use
of CHTC within this key population [110]. Since testing is
crucial for prevention, understanding barriers to testing
among HIV-negative partners and designing interventions
to increase uptake should be a focus of future work.
Highly vulnerable non-IDU populations, including trans-
gender persons and migrants, have been inadequately
studied [45,46,87,97,111,112]. African-American people in
the United States were represented within the series of
papers generated by the Eban study that assessed the
impact of a behavioural intervention on HIV risk be-
haviours within multiple urban settings in the United
States [20,21]. The high infection rates observed among
some African-American MSM may be attributable to low
rates of diagnosis and treatment rather than patterns of
risk behaviour [113], underscoring the importance of ex-
ploring research approaches that are sensitized to the social
determinants of health.
Studies of reproductive issues among same-sex serodiscor-
dant couples were entirely absent, despite the fact that 19%
of same-sex couples in the United States were estimated to
have children as of 2011 [114]. Although same-sex male
couples do not experience transmission risk associated with
procreative sex, the decision to have children and its impacts
on relationship dynamics within this relationship context
should be taken up in future studies.
Currently, very few studies have investigated barriers
to disclosing a serodiscordant relationship to family and
social networks, and the impacts of these decisions on
the relationship. These impacts could be psychosocial,
or may affect access to supportive services. In one of the
very few studies on the subject, better perceived social
integration facilitated a better likelihood of relationship
disclosure by HIV-positive partners to their social net-
works when compared with their seronegative partners
[88]. Given the tremendous stigma associated with HIV
in particular settings, there is a need to better under-
stand the impact of disclosure to family and social net-
works on access to supportive services and uptake of
HIV risk management strategies within the couple. There
were also very few studies that investigated associations
between serostatus disclosure and sexual risk with primary
partners. Future dyadic work would need to be limited to
studies that aimed to recruit only the HIV-positive part-
ner, given the couple’s self-identification as serodiscordant
would need to be known by both the HIV-positive and
HIV-negative partner in advance of recruitment. In
cases where disclosure had not yet occurred between
partners, it would not be possible to confirm the HIV-
serodiscordant, primary relationship status of the couple
that would be necessary for eligibility in a study that
focused on this unit of analysis.
Only one-third of included studies recruited dyads, de-
fined as both partners within a serodiscordant relation-
ship. Therefore, the majority of studies relied on the
responses of a single partner. Given the importance of
interpersonal dynamics within a relationship, studies
that recruit both partners of a serodiscordant couple are
crucial for understanding the management of risk, the
cultivation of intimacy within the couple, and changes
over time. Dyadic studies also enhance the validity of
outcome variables by devising ways of operationalizing
the responses of both partners through techniques such
as agreement scores. If couples-based approaches are to
be employed within HIV prevention interventions, more
studies focused on the dyad as the unit of analysis will
be needed. Given the challenges of recruiting representa-
tive cohorts of HIV-serodiscordant dyads, methodo-
logical work that describes challenges and solutions
would be helpful.
Population-based cohort studies would also help to in-
crease our understanding of the epidemiological profile
Mendelsohn et al. BMC Public Health  (2015) 15:241 Page 13 of 18
of serodiscordant couples, and would help to develop
targeted programs that deliver single or combination
HIV prevention interventions to couples that are most
in need. Given the preponderance of studies focused on
sexual risk behaviour and the movement away from
viewing all unprotected anal or vaginal intercourse, or
sex without condoms, as risky (i.e., due to variable risk
associated with condomless sex across different risk en-
vironments), a review of the ways in which the evidence
base has typically operationalized “risky sexual behav-
iour” would be a strong contribution to the literature.
Finally, a major weakness of the literature was in the
aggregation of results in studies that recruited mixed
populations of couples (e.g., casual, primary, serodis-
cordant, seroconcordant) without presenting stratified
results. This aggregation complicated comparability and
synthesis of data. Therefore, if primary couples are to be
considered different with respect to risk, they should be
properly distinguished and discussed within larger studies.
Only eight intervention studies met the inclusion cri-
teria for this scoping review. Published trials included
behavioural interventions to reduce sexual risk [20-24], a
psycho-educational group intervention to reduce depres-
sion and anxiety and increase marital satisfaction [25],
an intervention to improve adherence to ART [26], and
two interventions for improving social support [27,28].
Therefore, major gaps exists in relation to evaluated in-
terventions designed to support serodiscordant couples
in establishing a routine HIV-testing schedule, improv-
ing the quality of their relationships, supporting the
navigation of negotiated safety agreements, and consist-
ently executing seroadaptive strategies.
There were strengths and limitations to this review.
Strengths included the thorough database searching and
broad inclusion criteria (i.e., any study with a proportion
of primary serodiscordant couples). Limitations included
the omission of grey literature and reports published in
languages other than English. Work that includes mixed
cohorts, such as serodiscordant and seroconcordant cou-
ples, or primary and casual relationships, should identify
these sample proportions clearly, provide consistent defi-
nitions, and conduct stratified analyses. Consistently de-
fined outcomes and populations will facilitate helpful
meta-analyses, the highest form of evidence.
Conclusions
In summary, our findings highlight where future research
on HIV-serodiscordant relationships may be directed, in-
cluding the effects of risk management strategies on rela-
tionship quality, the social determinants of health for
serodiscordant couples, dynamics around HIV testing, re-
productive issues among same-sex couples, disclosure of
serodiscordant status to social networks, dyadic studies,
population-based studies and studies among vulnerable
populations. Importantly, as HIV-positive partners are
often the link to services and research, innovative ways are
needed to reach out to HIV-negative partners in the con-
text of research studies and supportive services. Overall,
filling these gaps will be important for improving the
health and quality of life for HIV-positive and HIV-
negative partners engaged in serodiscordant relationships.
Additional file
Additional file 1: Table S1. Sample systematic review search strategy
used in MEDLINE*.
Competing interests
The authors declare that they have no competing interests
Authors’ contributions
JBM and LC developed the idea for the paper. SM and JP conducted
searches. JBM, SM, and JP assessed citations for inclusion. JBM and SM
thematically categorized included citations. JBM wrote the first draft of the
manuscript. AD, DA, AB, ML, SM, JP, and TM commented on the manuscript.
All authors read, commented on, and approved the final manuscript.
Acknowledgments
The authors acknowledge seed grant funding from The CIHR Social Research
Centre in HIV Prevention, Dalla Lana School of Public Health, University of
Toronto, Canada.
Author details
1Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
2Centre for the AIDS Programme of Research in South Africa (CAPRISA),
University of KwaZulu Natal, Durban, South Africa. 3Sigma Research Group,
London School of Hygiene and Tropical Medicine, London, UK. 4Women’s
College Research Institute, Women’s College Hospital, University of Toronto,
Toronto, ON, Canada.
Received: 16 September 2014 Accepted: 28 January 2015
References
1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report:
UNAIDS Report on the Global AIDS Epidemic Geneva. 2012. http://www.
unaids.org/sites/default/files/media_asset/20121120_UNAIDS_Global_Report_
2012_with_annexes_en_1.pdf.
2. Public Health Agency of Canada: Summary: Estimates of HIV Prevalence and
Incidence in Canada, 2011. Ottawa; 2012. http://www.who.int/hiv/pub/
guidelines/9789241501972/en/
3. Chemaitelly H, Cremin I, Shelton J, Hallett TB, Abu-Raddad LJ. Distinct HIV
discordancy patterns by epidemic size in stable sexual partnerships in
sub-Saharan Africa. Sex Transm Infect. 2012;88(1):51–7.
4. World Health Organization: Guidance on couples HIV testing and
counselling including antiretroviral therapy for treatment and prevention in
serodiscordant couples. Geneva; 2012. http://www.phac-aspc.gc.ca/aids-
sida/publication/survreport/estimat2011-eng.php
5. Loutfy MR, Wu W, Letchumanan M, Bondy L, Antoniou T, Margolese S, et al.
Systematic review of HIV transmission between heterosexual serodiscordant
couples where the HIV-positive partner is fully suppressed on antiretroviral
therapy. PLoS One. 2013;8(2):e55747.
6. Del Romero J, Castilla J, Hernando V, Rodriguez C, Garcia S. Combined
antiretroviral treatment and heterosexual transmission of HIV-1: cross
sectional and prospective cohort study. BMJ. 2010;340:c2205.
7. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC,
Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral
therapy. N Engl J Med. 2011;365(6):493–505.
8. Persson A. Notes on the concepts of ‘serodiscordance’ and ‘risk’ in couples
with mixed HIV status. Glob Public Health. 2013;8(2):209–20.
Mendelsohn et al. BMC Public Health  (2015) 15:241 Page 14 of 18
9. Remien RH, Carballo-Dieguez A, Wagner G. Intimacy and sexual risk behavior
in serodiscordant male couples. Aids Care. 1995;7(4):429–38.
10. Skurnick JH, Abrams J, Kennedy CA, Valentine SN, Cordell JR. Maintenance
of safe sex behavior by HIV-serodiscordant heterosexual couples. AIDS Educ
Prev. 1998;10(6):493–505.
11. van der Straten A, Vernon KA, Knight KR, Gomez CA, Padian NS. Managing
HIV among serodiscordant heterosexual couples: serostatus, stigma and sex.
AIDS Care. 1998;10(5):533–48.
12. Vandevanter N, Thacker AS, Bass G, Arnold M. Heterosexual couples
confronting the challenges of HIV infection. AIDS Care. 1999;11(2):181–93.
13. Wagner GJ, Remien RH, Carballo-Dieguez A. “Extramarital” sex: is there an
increased risk for HIV transmission? A study of male couples of mixed
HIV status. AIDS Educ Prev. 1998;10(3):245–56.
14. Wagner GJ, Remien RH, Carballo-Dieguez A. Prevalence of extradyadic sex
in male couples of mixed HIV status and its relationship to psychological
distress and relationship quality. J Homosex. 2000;39(2):31–46.
15. Arksey H, O’Malley L. Scoping studies: towards a methodological framework.
Int J Soc Res Methodol. 2005;8(1):19–32.
16. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting
items for systematic reviews and meta-analyses: the PRISMA statement.
PLoS Med. 2009;6(7):e1000097.
17. Mays N, Pope C, Popay J. Systematically reviewing qualitative and
quantitative evidence to inform management and policy-making in the
health field. J Health Serv Res Policy. 2005;10 Suppl 1:6–20.
18. World Bank. Glossary. 2003. 2012.
19. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In:
Bryman A, Burgess RG, editors. Analyzing Qualitative Data. London:
Routledge; 1994. p. 173–94.
20. NIMH Multisite HIV/STD Prevention Trial for African American Couples
Group. Formative study to develop the Eban treatment and
comparison interventions for couples. J Acquir Immune Defic Syndr.
2008;49 Suppl 1:S42–51.
21. El-Bassel N, Jemmott JB, Landis JR, Pequegnat W, Wingood GM, Wyatt GE,
et al. National Institute of Mental Health Multisite Eban HIV/STD Prevention
Intervention for African American HIV Serodiscordant Couples: a cluster
randomized trial. Arch Intern Med. 2010;170(17):1594–601.
22. Rosser BR, Hatfield LA, Miner MH, Ghiselli ME, Lee BR, Welles SL, et al.
Effects of a behavioral intervention to reduce serodiscordant unsafe sex
among HIV positive men who have sex with men: the Positive Connections
randomized controlled trial study. J Behav Med. 2010;33(2):147–58.
23. Wyatt GE, Longshore D, Chin D, Carmona JV, Loeb TB, Myers HF, et al. The efficacy
of an integrated risk reduction intervention for HIV-positive women with child
sexual abuse histories. AIDS Behav. 2004;8(4):453–62.
24. Hernando V, del Romero J, Garcia S, Rodriguez C, del Amo J, Castilla J.
Reducing sexual risk behavior among steady heterosexual serodiscordant
couples in a testing and counseling program. Sex Transm Dis. 2009;36(10):621–8.
25. Pomeroy EC, Green DL, Van Laningham L. Couples who care: The
effectiveness of a psychoeducational group intervention for HIV
serodiscordant couples. Res Soc Work Prac. 2002;12(2):238–52.
26. Remien RH, Stirratt MJ, Dolezal C, Dognin JS, Wagner GJ, Carballo-Dieguez A,
et al. Couple-focused support to improve HIV medication adherence:
a randomized controlled trial. AIDS. 2005;19(8):807–14.
27. Gordon-Garofalo VL, Rubin A. Evaluation of a psychoeducational group for
seronegative partners and spouses of persons with HIV/AIDS. Res Soc Work
Prac. 2004;14(1):14–26.
28. Fife BL, Scott LL, Fineberg NS, Zwickl BE. Promoting adaptive coping by
persons with HIV disease: evaluation of a patient/partner intervention model.
J Assoc Nurses AIDS Care. 2008;19(1):75–84.
29. Milam J, Richardson JL, Espinoza L, Stoyanoff S. Correlates of unprotected
sex among adult heterosexual men living with HIV. J Urban Health.
2006;83(4):669–81.
30. Bouhnik AD, Preau M, Lert F, Peretti-Watel P, Schiltz MA, Obadia Y, et al.
Unsafe sex in regular partnerships among heterosexual persons living with HIV:
evidence from a large representative sample of individuals attending outpatients
services in France (ANRS-EN12-VESPA Study). AIDS. 2007;21 Suppl 1:S57–62.
31. Aidala AA, Lee G, Howard JM, Caban M, Abramson D, Messeri P. HIV-positive
men sexually active with women: sexual behaviors and sexual risks. J Urban
Health. 2006;83(4):637–55.
32. Kalichman SC, Rompa D, Luke W, Austin J. HIV transmission risk behaviours
among HIV-positive persons in serodiscordant relationships. Int J STD AIDS.
2002;13(10):677–82.
33. Tieu HV, Xu G, Bonner S, Spikes P, Egan JE, Goodman K, et al. Sexual partner
characteristics, serodiscordant/serostatus unknown unprotected anal
intercourse and disclosure among human immunodeficiency virus-infected
and uninfected black men who have sex with men in New York City.
Sex Transm Dis. 2011;38(6):548–54.
34. Poppen PJ, Reisen CA, Zea MC, Bianchi FT, Echeverry JJ. Serostatus
disclosure, seroconcordance, partner relationship, and unprotected anal
intercourse among HIV-positive Latino men who have sex with men.
AIDS Educ Prev. 2005;17(3):227–37.
35. Semple SJ, Zians J, Grant I, Patterson TL. Sexual risk behavior of HIV-positive
methamphetamine-using men who have sex with men: the role of partner
serostatus and partner type. Arch Sex Behav. 2006;35(4):461–71.
36. Hoff CC, Gomez C, Faigeles B, Purcell DW, Halkitis PN, Parsons JT, et al.
Serostatus of primary partner impacts sexual behavior inside and outside
the relationship: a description of HIV-positive MSM in primary relationships.
J Psychol Hum Sex. 2004;16(4):77–95.
37. Crawford I, Hammack PL, McKirnan DJ, Ostrow D, Zamboni BD, Robinson B,
et al. Sexual sensation seeking, reduced concern about HIV and sexual risk
behaviour among gay men in primary relationships. AIDS Care. 2003;15(4):513–24.
38. Theodore PS, Duran RE, Antoni MH, Fernandez MI. Intimacy and sexual
behavior among HIV-positive men who have sex with men in primary
relationships. AIDS Behav. 2004;8(3):321–31.
39. Blashill AJ, O’Cleirigh C, Mayer KH, Goshe BM, Safren SA. Body mass index,
depression and sexual transmission risk behaviors among HIV-positive MSM.
AIDS Behav. 2012;16(8):2251–6.
40. Bradley MV, Remien RH, Dolezal C. Depression symptoms and sexual
HIV risk behavior among serodiscordant couples. Psychosom Med.
2008;70(2):186–91.
41. Israel H, Romeis J, Spitz T. Sensation seeking and HIV serodiscordant
couples. J Assoc Nurses AIDS Care. 2005;16(6):3–11.
42. Simoni JM, Walters KL, Nero DK. Safer sex among HIV+ women: the role of
relationships. Sex Roles. 2000;42(7–8):691–708.
43. Theall KP, Clark RA, Powell A, Smith H, Kissinger P. Alcohol consumption,
ART usage and high-risk sex among women infected with HIV. AIDS Behav.
2007;11(2):205–15.
44. Latka MH, Metsch LR, Mizuno Y, Tobin K, Mackenzie S, Arnsten JH, et al.
Unprotected sex among HIV-positive injection drug-using women and their
serodiscordant male partners: role of personal and partnership influences.
J Acquir Immune Defic Syndr. 2006;42(2):222–8.
45. Operario D, Nemoto T, Iwamoto M, Moore T. Unprotected sexual behavior
and HIV risk in the context of primary partnerships for transgender women.
AIDS Behav. 2011;15(3):674–82.
46. Operario D, Nemoto T, Iwamoto M, Moore T. Risk for HIV and unprotected
sexual behavior in male primary partners of transgender women. Arch
Sex Behav. 2011;40(6):1255–61.
47. Horvath KJ, Smolenski D, Iantaffi A, Grey JA, Rosser BR. Discussions of viral
load in negotiating sexual episodes with primary and casual partners
among men who have sex with men. AIDS Care. 2012;24(8):1052–5.
48. Guzman R, Buchbinder S, Mansergh G, Vittinghoff E, Marks G, Wheeler S,
et al. Communication of HIV viral load to guide sexual risk decisions with
serodiscordant partners among San Francisco men who have sex with men.
AIDS Care. 2006;18(8):983–9.
49. Prestage G, Mao L, Kippax S, Jin F, Hurley M, Grulich A, et al. Use of viral
load to negotiate condom use among gay men in Sydney, Australia. AIDS
Behav. 2009;13(4):645–51.
50. Van de Ven P, Mao L, Fogarty A, Rawstorne P, Crawford J, Prestage G, et al.
Undetectable viral load is associated with sexual risk taking in HIV
serodiscordant gay couples in Sydney. AIDS. 2005;19(2):179–84.
51. van der Straten A, Gomez CA, Saul J, Quan J, Padian N. Sexual risk behaviors
among heterosexual HIV serodiscordant couples in the era of post-exposure
prevention and viral suppressive therapy. AIDS. 2000;14(4):F47–54.
52. Eaton A. Potential risk factors for HIV transmission in heterosexual HIV
discordant couples: intimate partner violence, antiretroviral therapies
and concurrent sexual partners. Diss Abstr Int: Section B: Sci Eng.
2008;68(8-B):5110.
53. Stolte IG, de Wit JB, van Eeden A, Coutinho RA, Dukers NH. Perceived viral
load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour
among HIV-infected homosexual men. AIDS. 2004;18(14):1943–9.
54. Persson A. Reflections on the Swiss Consensus Statement in the context
of qualitative interviews with heterosexuals living with HIV. AIDS Care.
2010;22(12):1487–92.
Mendelsohn et al. BMC Public Health  (2015) 15:241 Page 15 of 18
55. Kippax S, Noble J, Prestage G, Crawford JM, Campbell D, Baxter D, et al. Sexual
negotiation in the AIDS era: negotiated safety revisited. AIDS. 1997;11(2):191–7.
56. Elford J, Bolding G, Maguire M, Sherr L. Sexual risk behaviour among gay
men in a relationship. AIDS. 1999;13(11):1407–11.
57. Hoff CC, Chakravarty D, Beougher SC, Darbes LA, Dadasovich R, Neilands TB.
Serostatus differences and agreements about sex with outside partners
among gay male couples. AIDS Educ Prev. 2009;21(1):25–38.
58. Ostrow DG, Silverberg MJ, Cook RL, Chmiel JS, Johnson L, Li X, et al.
Prospective study of attitudinal and relationship predictors of sexual risk in
the multicenter AIDS cohort study. AIDS Behav. 2008;12(1):127–38.
59. Chakravarty D, Hoff CC, Neilands TB, Darbes LA. Rates of testing for HIV in
the presence of serodiscordant UAI among HIV-negative gay men in
committed relationships. AIDS Behav. 2012;16(7):1944–8.
60. NIMH Multisite HIV/STD Prevention Trial for African American Couples
Group. Concordant and discordant reports on shared sexual behaviors and
condom use among African American serodiscordant couples in four cities.
AIDS Behav. 2010;14(5):1011–22.
61. Fox J, Alsop A, Elam G, Green J, Weber J, Ward H, et al. Understanding HIV-risk
behaviour in HIV-serodiscordant couples - A novel approach (15th Annual
Conference of the British HIV Association Liverpool United Kingdom).
HIV Med. 2009;10:54.
62. Crawford JM, Rodden P, Kippax S, Van de Ven P. Negotiated safety and
other agreements between men in relationships: risk practice redefined.
Int J STD AIDS. 2001;12(3):164–70.
63. Hoff CC, Beougher SC. Sexual agreements among gay male couples.
Arch Sex Behav. 2010;39(3):774–87.
64. Cusick L, Rhodes T. Sustaining sexual safety in relationships: HIV positive
people and their sexual partners. Cult Health Sex. 2000;2(4):473–87.
65. Davis M, Flowers P. Love and HIV serodiscordance in gay men’s accounts of
life with their regular partners. Cult Health Sex. 2011;13(7):737–49.
66. Rhodes T, Cusick L. Love and intimacy in relationship risk management: HIV
positive people and their sexual partners. Soc Health Ill. 2000;22(1):1–26.
67. Xia Q, Molitor F, Osmond DH, Tholandi M, Pollack LM, Ruiz JD, et al. Knowledge of
sexual partner’s HIV serostatus and serosorting practices in a California
population-based sample of men who have sex with men. AIDS.
2006;20(16):2081–9.
68. Liu C, Hu H, Goparaju L, Plankey M, Bacchetti P, Weber K, et al. Sexual serosorting
among women with or at risk of HIV infection. AIDS Behav. 2011;15(1):9–15.
69. Dave SS, Stephenson J, Mercey DE, Panahmand N, Jungmann E. Sexual
behaviour, condom use, and disclosure of HIV status in HIV infected
heterosexual individuals attending an inner London HIV clinic. Sex Transm
Infect. 2006;82(2):117–9. discussion 119–120.
70. Hart TA, Wolitski RJ, Purcell DW, Parsons JT, Gomez CA, Seropositive Urban
Men’s Study T. Partner awareness of the serostatus of HIV-seropositive men
who have sex with men: impact on unprotected sexual behavior. AIDS
Behav. 2005;9(2):155–66.
71. Gosselin JT, Sauer MV. Life after HIV: examination of HIV serodiscordant
couples’ desire to conceive through assisted reproduction. AIDS Behav.
2011;15(2):469–78.
72. Fletcher FE. A qualitative approach to understanding pregnancy intentions
among Black women living with HIV in South Carolina. Diss Abstr Int:
Section B: Sci Eng. 2012;72(11-B):6700.
73. Noestlinger C, Desjardins F. Child desire in women and men living with HIV
attending HIV outpatient clinics: evidence from a European multicentre
study (12th Congress of the European Society of Contraception and Reproductive
Health Athens Greece). Eur J Contracept Reprod Health Care. 2012;17:S83.
74. Kelly C, Lohan M, Alderdice F, Spence D. Negotiation of risk in sexual
relationships and reproductive decision-making amongst HIV sero-different
couples. Cult Health Sex. 2011;13(7):815–27.
75. Sunderam S, Hollander L, Macaluso M, Vucetich A, Jamieson DJ, Osimo F,
et al. Safe conception for HIV discordant couples through sperm-washing:
experience and perceptions of patients in Milan, Italy. Reprod Health Matters.
2008;16(31):211–9.
76. Persson A. Sero-silence and sero-sharing: managing HIV in serodiscordant
heterosexual relationships. AIDS Care. 2008;20(4):503–6.
77. Persson A. HIV-negativity in serodiscordant relationships: the absence,
enactment, and liminality of serostatus identity. Med Anthropol.
2011;30(6):569–90.
78. Palmer R, Bor R. The challenges to intimacy and sexual relationships for gay
men in HIV serodiscordant relationships: a pilot study. J Marital Fam Ther.
2001;27(4):419–31.
79. Gaskins S. Issues for women with heterosexually transmitted HIV disease.
AIDS Patient Care STDS. 1999;13(2):89–96.
80. Kalichman SC, Nachimson D. Self-efficacy and disclosure of HIV-positive
serostatus to sex partners. Health Psychol. 1999;18(3):281–7.
81. Niccolai LM, Farley TA, Ayoub MA, Magnus M, Kissinger PJ. HIV-infected
persons knowledge of their sexual partners’ HIV status. AIDS Educ Prev.
2002;14(3):183–9.
82. Parsons JT, Missildine W, Van Ora J, Purcell DW, Gomez CA, Seropositive Urban
Drug Injectors S. HIV serostatus disclosure to sexual partners among HIV-positive
injection drug users. AIDS Patient Care STDS. 2004;18(8):457–69.
83. Sullivan K. Male self-disclosure of HIV infection to sex partners: a Hawaii-based
sample. J Assoc Nurses AIDS Care. 2009;20(6):442–57.
84. Cusick L, Rhodes T. The process of disclosing positive HIV status: findings
from qualitative research. Cult Health Sex. 1999;1(1):3–18.
85. Sowell RL, Seals BF, Phillips KD, Julious CH. Disclosure of HIV infection: how
do women decide to tell? Health Educ Res. 2003;18(1):32–44.
86. Bairan A, Taylor GA, Blake BJ, Akers T, Sowell R, Mendiola Jr R. A model of
HIV disclosure: disclosure and types of social relationships. J Am Acad Nurse
Pract. 2007;19(5):242–50.
87. Chin D, Kroesen KW. Disclosure of HIV infection among Asian/Pacific
Islander American women: cultural stigma and support. Cult Divers Ethnic
Minor Psychol. 1999;5(3):222–35.
88. Greenberg JD. The impact of disclosure of mixed HIV status on social
support, relationship satisfaction, and psychological distress for male mixed
status couples. In: Dissertation/Thesis. New York: Fordham University; 2001.
89. Wagner GJ, Remien RH, Carballo-Dieguez A, Dolezal C. Correlates of
adherence to combination antiretroviral therapy among members of
HIV-positive mixed status couples. AIDS Care. 2002;14(1):105–9.
90. Johnson MO, Dilworth SE, Neilands TB. Partner reports of patients’ HIV
treatment adherence. J Acquir Immune Defic Syndr. 2011;56(4):e117–8.
91. Wrubel J, Stumbo S, Johnson MO. Male same sex couple dynamics and
received social support for HIV medication adherence. J Soc Pers Relat.
2010;27(4):553–72.
92. Knowlton AR, Yang C, Bohnert A, Wissow L, Chander G, Arnsten JA. Informal care
and reciprocity of support are associated with HAART adherence among men in
Baltimore, MD, USA. AIDS Behav. 2011;15(7):1429–36.
93. Wrubel J, Stumbo S, Johnson MO. Antiretroviral medication support
practices among partners of men who have sex with men: a qualitative
study. AIDS Patient Care STDS. 2008;22(11):851–8.
94. Knowlton AR, Yang C, Bohnert A, Wissow L, Chander G, Arnsten JA. Main partner
factors associated with worse adherence to HAART among women in Baltimore,
Maryland: a preliminary study. AIDS Care. 2011;23(9):1102–10.
95. Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D, et al.
The role of HIV serostatus disclosure in antiretroviral medication adherence.
AIDS Behav. 2006;10(5):483–93.
96. Peretti-Watel P, Spire B, Schiltz MA, Bouhnik AD, Heard I, Lert F, et al.
Vulnerability, unsafe sex and non-adherence to HAART: evidence from a
large sample of French HIV/AIDS outpatients. Soc Sci Med. 2006;62(10):2420–33.
97. Doyal L, Anderson J. ‘My fear is to fall in love again…’ how HIV-positive
African women survive in London. Soc Sci Med. 2005;60(8):1729–38.
98. Crane J, Quirk K, van der Straten A. “Come back when you”re dying:“ the
commodification of AIDS among California’s urban poor. Soc Sci Med.
2002;55(7):1115–27.
99. NIMH Multisite HIV/STD Prevention Trial for African American Couples
Group. Prevalence of child and adult sexual abuse and risk taking
practices among HIV serodiscordant African-American couples. AIDS Behav.
2010;14(5):1032–44.
100. Myers HF, Wyatt GE, Loeb TB, Carmona JV, Warda U, Longshore D, et al.
Severity of child sexual abuse, post- traumatic stress and risky sexual
behaviors among HIV-positive women. AIDS Behav. 2006;10(2):191–9.
101. Haas SM. Social support as relationship maintenance in gay male couples
coping with HIV or AIDS. J Soc Pers Relat. 2002;19(1):87–111.
102. Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV
prevention: where have we been and where are we going? J Acquir
Immune Defic Syndr. 2013;63 Suppl 2:S122–9.
103. Gupta RK, Wainberg MA, Brun-Vezinet F, Gatell JM, Albert J, Sonnerborg A,
et al. Oral antiretroviral drugs as public health tools for HIV prevention:
global implications for adherence, drug resistance, and the success of
HIV treatment programs. J Infect Dis. 2013;207 Suppl 2:S101–6.
104. Wilson TE, Feldman J, Vega MY, Gandhi M, Richardson J, Cohen MH, et al.
Acquisition of new sexual partners among women with HIV infection:
Mendelsohn et al. BMC Public Health  (2015) 15:241 Page 16 of 18
patterns of disclosure and sexual behavior within new partnerships. AIDS
Educ Prev. 2007;19(2):151–9.
105. Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, Vanable PA, et al.
Attitudes towards highly active antiretroviral therapy are associated with
sexual risk taking among HIV-infected and uninfected homosexual men.
AIDS. 2002;16(5):775–80.
106. Auerbach J, Parkhurst J, Cáceres C. Addressing social drivers of HIV/AIDS for
the long-term response: conceptual and methodological considerations.
Glob Public Health. 2011;6 Suppl 3:S293–309.
107. Lazzarini Z, Galletly CL, Mykhalovskiy E, Harsono D, O’Keefe E, Singer M,
et al. Criminalization of HIV transmission and exposure: research and policy
agenda. Am J Public Health. 2013;103(8):1350–3.
108. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB,
et al. Revised recommendations for HIV testing of adults, adolescents,
and pregnant women in health-care settings. MMWR Recomm Rep.
2006;55(RR-14):1–17. quiz CE11-14.
109. Moyer VA, U. S. Preventive Services Task Force. Screening for HIV: U.S.
Preventive Services Task Force Recommendation Statement. Ann Intern Med.
2013;159(1):51–60.
110. Purcell DW, Mizuno Y, Smith DK, Grabbe K, Courtenay-Quick C,
Tomlinson H, et al. Incorporating couples-based approaches into HIV
prevention for gay and bisexual men: opportunities and challenges.
Arch Sex Behav. 2014;43(1):35–46.
111. Elford J, Ibrahim F, Bukutu C, Anderson J. Disclosure of HIV status: the role
of ethnicity among people living with HIV in London. J Acquir Immune
Defic Syndr. 2008;47(4):514–21.
112. Asander AS, Bjorkman A, Belfrage E, Faxelid E. HIV-infected African parents
living in Stockholm, Sweden: disclosure and planning for their children’s
future. Health Soc Work. 2009;34(2):107–15.
113. Centers for Disease Control and Prevention: HIV among African Americans.
Atlanta; 2013. http://www.cdc.gov/hiv/pdf/risk_HIV_AAA.pdf
114. US Census Bureau: Same-sex couple households. Washington DC; 2011.
http://www.census.gov/prod/2011pubs/acsbr10-03.pdf
115. Aoki E. An Interpersonal and Intercultural Embrace: A Letter of Reflection on
My Gay Male Relational Connections, Relationship Therapy with Same-Sex
Couples. 2004. p. 111–21.
116. Beckerman NL, Letteney S, Lorber K. Key emotional issues for couples of
mixed HIV status. Soc Work Health Care. 2000;31(4):25–41.
117. Beckerman NL. Serodiscordant couples in the age of combination therapies:
challenges and coping patterns. J HIV AIDS Soc Serv. 2002;1(3):67–80.
118. Beckerman NL. Couples coping with discordant HIV status. AIDS Patient
Care STDS. 2002;16(2):55–9.
119. Beckerman NL, Auerbach C. Couples of mixed HIV status: psychosocial
issues affecting intimacy. J Couple Relatsh Ther. 2002;1(4):73–85.
120. Brooks RA, Kaplan RL, Lieber E, Landovitz RJ, Lee SJ, Leibowitz AA.
Motivators, concerns, and barriers to adoption of preexposure prophylaxis
for HIV prevention among gay and bisexual men in HIV-serodiscordant male
relationships. AIDS Care. 2011;23(9):1136–45.
121. Brooks RA, Landovitz RJ, Kaplan RL, Lieber E, Lee SJ, Barkley TW. Sexual risk
behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative
gay and bisexual men in serodiscordant relationships: a mixed methods study.
AIDS Patient Care STDS. 2012;26(2):87–94.
122. Buchacz K, van der Straten A, Saul J, Shiboski SC, Gomez CA, Padian N.
Sociodemographic, behavioral, and clinical correlates of inconsistent
condom use in HIV-serodiscordant heterosexual couples. J Acquir Immune
Defic Syndr. 2001;28(3):289–97.
123. Chen JL, Philips KA, Kanouse DE, Collins RL, Miu A. Fertility desires and
intentions of HIV-positive men and women. Fam Plann Perspect.
2001;33(4):144. –152, 165.
124. Coll O, Azulay M, Newell ML, Vidal R, Cararach V, Vanrell JA. HIV-serodiscordant
couples seeking assisted reproduction. Prenat Neonatal Med. 1999;4(5):362–7.
125. Cooney G, Cohen C, Day S. Understanding the sexual and reproductive
health needs of women living with HIV. Abstract P19, HIV Medicine.
2009;10(supplement 1):11–56.
126. Corbett AM, Dickson-Gomez J, Hilario H, Weeks MR. A little thing called love:
condom use in high-risk primary heterosexual relationships. Perspect Sex
Reprod Health. 2009;41(4):218–24.
127. Cranson DA, Caron SL. An investigation of the effects of HIV on the sex lives
of infected individuals. AIDS Educ Prev. 1998;10(6):506–22.
128. Crawford JM, Kippax SC, Mao L, Van de Ven PG, Prestage GP, Grulich AE,
et al. Number of risk acts by relationship status and partner serostatus:
findings from the HIM cohort of homosexually active men in Sydney,
Australia. AIDS Behav. 2006;10(3):325–31.
129. Crosby R, Holtgrave DR, Stall R, Peterson JL, Shouse L. Differences in HIV risk
behaviors among black and white men who have sex with men.
Sex Transm Dis. 2007;34(10):744–8.
130. Davidovich U, de Wit J, Albrecht N, Geskus R, Stroebe W, Coutinho R.
Increase in the share of steady partners as a source of HIV infection: a
17-year study of seroconversion among gay men. AIDS. 2001;15(10):1303–8.
131. Dolezal C, Remien RH, Wagner GJ, Carballo-Dieguez A, Hung Y. Alcohol,
marijuana, cocaine use, and relationship quality among HIV serodiscordant
male couples. Am J Drug Alcohol Abuse. 2005;31(4):593–600.
132. Eaton LA, West TV, Kenny DA, Kalichman SC. HIV transmission risk among
HIV seroconcordant and serodiscordant couples: dyadic processes of
partner selection. AIDS Behav. 2009;13(2):185–95.
133. Eaton A, van Der Straten A. Concurrent sexual partnerships among
individuals in HIV sero-discordant heterosexual couples. Int J STD AIDS.
2009;20(10):679–82.
134. NIMH Multisite HIV/STD Prevention Trial for African American Couples
Group. The contribution of male and female partners’ substance use to
sexual risks and STDs among African American HIV serodiscordant couples.
AIDS Behav. 2010;14(5):1045–54.
135. NIMH Multisite HIV/STD Prevention Trial for African American Couples
Group. Risky sexual behavior and correlates of STD prevalence among
African American HIV serodiscordant couples. AIDS Behav. 2010;14(5):1023–31.
136. Estes JL. HIV-serodiscordant couples: adjustment and adaptation
responses to living with HIV-infection. Diss Abstr Int Section A: Hum Soc Sci.
1997;58(5-A):1939.
137. Galvan FH, Collins R, Kanouse DE, Burnam MA, Paddock SM, Beckman R,
et al. Abuse in the close relationships of people with HIV. AIDS Behav.
2004;8(4):441–51.
138. Gielen AC, McDonnell KA, Burke JG, O’Campo P. Women’s lives after an
HIV-positive diagnosis: disclosure and violence. Matern Child Health J.
2000;4(2):111–20.
139. Guy RJ, Spelman T, Stoove M, El-Hayek C, Goller J, Fairley CK, et al. Risk
factors for HIV seroconversion in men who have sex with men in
Victoria, Australia: results from a sentinel surveillance system. Sex Health.
2011;8(3):319–29.
140. Heard I, Potard V, Costagliola D, Kazatchkine MD. Contraceptive use in
HIV-positive women. J Acquir Immune Defic Syndr. 2004;36(2):714–20.
141. Heard I, Sitta R, Lert F, Group VS. Reproductive choice in men and women living
with HIV: evidence from a large representative sample of outpatients attending
French hospitals (ANRS-EN12-VESPA Study). AIDS. 2007;21 Suppl 1:S77–82.
142. Hotton A, Gratzer B, Pohl D, Mehta SD. Serosorting behaviours and beliefs
among MSM at an urban LGBT Health Center (19th Biennial Conference of
the International Society for Sexually Transmitted Diseases Research Quebec
City, QC Canada). Sex Transm Infect. 2011;87:A62–3.
143. Hunt WK, Myers H, Dyche M. Living with risk: male partners of HIV-positive
women. Cult Divers Ethnic Minor Psychol. 1999;5(3):276–86.
144. Jarman M, Walsh S, De Lacey G. Keeping safe, keeping connected: a
qualitative study of HIV-positive women’s experiences of partner relationships.
Psychol Health. 2005;20(4):533–51.
145. Kalichman SC. Psychological and social correlates of high-risk sexual
behaviour among men and women living with HIV/AIDS. AIDS Care.
1999;11(4):415–27.
146. Klein J, Pena JE, Thornton MH, Sauer MV. Understanding the motivations,
concerns, and desires of human immunodeficiency virus 1-serodiscordant
couples wishing to have children through assisted reproduction. Obstet
Gynecol. 2003;101(5 Pt 1):987–94.
147. Knight KR, Purcell D, Dawson-Rose C, Halkitis PN, Gomez CA, Seropositive
Urban Injectors Study T. Sexual risk taking among HIV-positive injection
drug users: contexts, characteristics, and implications for prevention. AIDS
Educ Prev. 2005;17(1 Suppl A):76–88.
148. Lopez EJ, Jones DL, Villar-Loubet OM, Arheart KL, Weiss SM. Violence, coping,
and consistent medication adherence in HIV-positive couples. AIDS Educ Prev.
2010;22(1):61–8.
149. Marks G, Crepaz N. HIV-positive men’s sexual practices in the context of
self-disclosure of HIV status. J Acquir Immune Defic Syndr. 2001;27(1):79–85.
150. Marujo AT, Correia L, Machado AI, Guerreiro C. Contraception in HIV-infected
women (12th Congress of the European Society of Contraception and
Reproductive Health Athens Greece). Eur J Contracept Reprod Health
Care. 2012;17:S66–7.
Mendelsohn et al. BMC Public Health  (2015) 15:241 Page 17 of 18
151. McDonald K. “The old-fashioned way’: conception and sex in serodiscordant
relationships after ART. Cult Health Sex. 2011;13(10):1119–33.
152. McFarland W, Chen YH, Raymond HF, Binh N, Colfax G, Mehrtens J, et al.
HIV seroadaptation among individuals, within sexual dyads, and by sexual
episodes, men who have sex with men, San Francisco, 2008. AIDS Care.
2011;23(3):261–8.
153. McFarland W, Chen YH, Nguyen B, Grasso M, Levine D, Stall R, et al.
Behavior, intention or chance? A longitudinal study of HIV seroadaptive
behaviors, abstinence and condom use. AIDS Behav. 2012;16(1):121–31.
154. Mizuno Y, Purcell DW, Latka MH, Metsch LR, Gomez CA, Latkin CA. Beliefs
that condoms reduce sexual pleasure-gender differences in correlates
among heterosexual HIV-positive injection drug users (IDUs). J Urban Health.
2007;84(4):523–36.
155. Nakhuda GS, Pena JE, Sauer MV. Deaths of HIV-positive men in the context
of assisted reproduction: five case studies from a single center. AIDS Patient
Care STDS. 2005;19(11):712–8.
156. Nichols CM. Coping responses, relationship satisfaction, and psychological
distress in male couples with serodiscordant HIV status. Diss Abstr Int:
Section B: Sci Eng. 2006;67(3-B):1710.
157. Nostlinger C, Niderost S, Gredig D, Platteau T, Gordillo V, Roulin C, et al.
Condom use with steady partners among heterosexual people living with
HIV in Europe: testing the information-motivation-behavioral skills model.
AIDS Patient Care STDS. 2010;24(12):771–80.
158. Panozzo L, Battegay M, Friedl A, Vernazza PL, Swiss Cohort S. High risk
behaviour and fertility desires among heterosexual HIV-positive patients
with a serodiscordant partner: two challenging issues. Swiss Med Wkly.
2003;133(7–8):124–7.
159. Parish KL, Cotton D, Huszti HC, Parsons JT, Hemophilia Behavioral Intervention
Study G. Safer sex decision-making among men with haemophilia and HIV
and their female partners. Haemophilia. 2001;7(1):72–81.
160. Parsons JT, Schrimshaw EW, Wolitski RJ, Halkitis PN, Purcell DW, Hoff CC,
et al. Sexual harm reduction practices of HIV-seropositive gay and bisexual
men: serosorting, strategic positioning, and withdrawal before ejaculation.
AIDS. 2005;19 Suppl 1:S13–25.
161. Persson A, Richards W. Vulnerability, gender and “proxy negativity”:
women in relationships with HIV-positive men in Australia. Soc Sci Med.
2008;67(5):799–807.
162. Poindexter CC. Sex, drugs, and love among the middle aged: a case study
of a serodiscordant heterosexual couple coping with HIV. J Soc Work Pract
Addict. 2003;3(2):57–83.
163. Prestage G, Jin F, Zablotska I, Grulich A, Imrie J, Kaldor J, et al. Trends in
agreements between regular partners among gay men in Sydney,
Melbourne and Brisbane, Australia. AIDS Behav. 2008;12(3):513–20.
164. Reilly T, Woo G. Predictors of high-risk sexual behavior among people living
with HIV/AIDS. AIDS Behav. 2001;5(3):205–17.
165. Reilly T, Woo G. Social support and maintenance of safer sex practices
among people living with HIV/AIDS. Health Soc Work. 2004;29(2):97–105.
166. Ritchie AJ, Kuldanek K, Moodie Z, Wang ZM, Fox J, Nsubuga RN, et al.
Comparison of sexual behavior and HIV risk between two HIV-1 serodiscordant
couple cohorts: the CHAVI 002 study. PLoS One. 2012;7(5):e37727.
167. Ross MW, Rosser BR, Neumaier ER, Positive Connections Team. The relationship
of internalized homonegativity to unsafe sexual behavior in HIV-seropositive
men who have sex with men. AIDS Educ Prev. 2008;20(6):547–57.
168. Schonnesson LN, Atkinson J, Williams ML, Bowen A, Ross MW, Timpson SC.
A cluster analysis of drug use and sexual HIV risks and their correlates in a
sample of African-American crack cocaine smokers with HIV infection. Drug
Alcohol Depend. 2008;97(1–2):44–53.
169. Semple SJ, Patterson TL, Grant I. Gender differences in the sexual risk practices
of HIV+ heterosexual men and women. AIDS Behav. 2002;6(1):205–17.
170. Service A. Modeling condom use in a statewide sample of HIV-positive
individuals. Diss Abstr Int: Section B: Sci Eng. 2006;67(4-B):2211.
171. Sherr L, Barry N. Fatherhood and HIV-positive heterosexual men. HIV Med.
2004;5(4):258–63.
172. Sowell RL, Phillips KD, Misener TR. HIV-infected women and motivation to
add children to their families. J Fam Nurs. 1999;5(3):316–31.
173. Stevens PE, Galvao L. “He won”t use condoms“: HIV-infected women’s
struggles in primary relationships with serodiscordant partners. Am J
Public Health. 2007;97(6):1015–22.
174. Stumbo S, Wrubel J, Johnson MO. A qualitative study of HIV treatment
adherence support from friends and family among same sex male couples.
Psychol Educ. 2011;2(4):318–22.
175. Suzan-Monti M, Preau M, Blanche J, Cabut S, Carrieri PM, Lert F, et al. The
burden of HIV experience and care among MSM having an HIV-positive
seroconcordant steady partner: a possible research hypothesis. Results
from the French VESPA ANRS EN-12 study. Sex Transm Infect. 2011;87(5):396–8.
176. Turner HA, Pearlin LI, Mullan JT. Sources and determinants of social support
for caregivers of persons with AIDS. J Health Soc Behav. 1998;39(2):137–51.
177. Van de Ven P, Kippax S, Crawford J, Rawstorne P, Prestage G, Grulich A,
et al. In a minority of gay men, sexual risk practice indicates strategic
positioning for perceived risk reduction rather than unbridled sex. AIDS
Care. 2002;14(4):471–80.
178. van Leeuwen E, Visser M, Prins JM, Nieuwkerk PT, van der Veen F. HIV
couples’ anxiety and risk taking during ART. Fertil Steril. 2008;90(2):456–8.
179. Vide Tavares M, Coutinho Nunes F, Rodrigues A, Saleiro S, Mota F, Torgal I.
Use of contraceptive methods by HIV-positive women (12th Congress of
the European Society of Contraception and Reproductive Health Athens
Greece). Eur J Contracept Reprod Health Care. 2012;17:S68–9.
180. Weinhardt LS, Kelly JA, Brondino MJ, Rotheram-Borus MJ, Kirshenbaum SB,
Chesney MA, et al. HIV transmission risk behavior among men and women
living with HIV in 4 cities in the United States. J Acquir Immune Defic Syndr.
2004;36(5):1057–66.
181. Wolitski RJ, Bailey CJ, O’Leary A, Gomez CA, Parsons JT, Seropositive Urban
Men’s S. Self-perceived responsibility of HIV-seropositive men who have sex
with men for preventing HIV transmission. AIDS Behav. 2003;7(4):363–72.
182. Wyatt GE, Loeb TB, Williams JK, Zhang M, Davis TD. A case study of sexual
abuse and psychological correlates among an HIV-serodiscordant couple.
Couple Fam Psychol. 2012;1(2):146–59.
183. Zablotska IB, Prestage G, Holt M, Poynten M, de Wit J, Guy R, et al.
Australian gay men who have taken nonoccupational postexposure
prophylaxis for HIV are in need of effective HIV prevention methods. J Acquir
Immune Defic Syndr. 2011;58(4):424–8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Mendelsohn et al. BMC Public Health  (2015) 15:241 Page 18 of 18
